Page last updated: 2024-08-21

levonorgestrel and Cardiovascular Stroke

levonorgestrel has been researched along with Cardiovascular Stroke in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's3 (37.50)18.2507
2000's4 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jick, H; Jick, S; Myers, MW; Vasilakis, C1
Schwingl, PJ; Shelton, J1
Koepsell, TD; Longstreth, WT; Petitti, DB; Psaty, BM; Quesenberry, CP; Raghunathan, TE; Schwartz, SM; Sidney, S; Siscovick, DS1
Colau, JC1
Algra, A; Cats, VM; Helmerhorst, FM; Kemmeren, JM; Rosendaal, FR; Tanis, BC; van den Bosch, MA; van der Graaf, Y1
Dubey, RK; Jäger, AW; Keller, PJ; Merki-Feld, GS; Rosselli, M1
Shapiro, S1
Croft, P; Hannaford, P1

Reviews

1 review(s) available for levonorgestrel and Cardiovascular Stroke

ArticleYear
[Contraception].
    Gynecologie, obstetrique & fertilite, 2000, Volume: 28, Issue:6

    Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraindications; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Progestins; Risk Factors; Stroke; Venous Thrombosis; Vinyl Compounds

2000

Trials

1 trial(s) available for levonorgestrel and Cardiovascular Stroke

ArticleYear
Long-term effects of combined oral contraceptives on markers of endothelial function and lipids in healthy premenopausal women.
    Contraception, 2002, Volume: 65, Issue:3

    Topics: Adult; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Cross-Over Studies; Endothelin-1; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Nitric Oxide; Norpregnenes; Premenopause; Prospective Studies; Statistics, Nonparametric; Time Factors

2002

Other Studies

6 other study(ies) available for levonorgestrel and Cardiovascular Stroke

ArticleYear
Risk of acute myocardial infarction and low-dose combined oral contraceptives.
    Lancet (London, England), 1996, Mar-02, Volume: 347, Issue:9001

    Topics: Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Myocardial Infarction; Norpregnenes; Progesterone Congeners; Risk; Smoking

1996
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
    Contraception, 1997, Volume: 55, Issue:3

    Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States

1997
Norplant implants and cardiovascular disease.
    Contraception, 1998, Volume: 57, Issue:5

    Topics: Adult; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptive Agents, Female; Drug Implants; Female; Humans; Levonorgestrel; Myocardial Infarction

1998
Oral contraceptives and the risk of myocardial infarction.
    The New England journal of medicine, 2001, Dec-20, Volume: 345, Issue:25

    Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Logistic Models; Middle Aged; Myocardial Infarction; Norpregnenes; Odds Ratio; Point Mutation; Prothrombin; Risk Factors; Smoking

2001
Oral contraceptives and the risk of myocardial infarction.
    The New England journal of medicine, 2002, Jun-06, Volume: 346, Issue:23

    Topics: Bias; Contraceptives, Oral; Female; Humans; Levonorgestrel; Myocardial Infarction; Risk Factors; Smoking; Surveys and Questionnaires

2002
Risk factors for acute myocardial infarction in women.
    BMJ (Clinical research ed.), 1989, Mar-11, Volume: 298, Issue:6674

    Topics: Acute Disease; Contraceptives, Oral, Combined; Female; Humans; Levonorgestrel; Myocardial Infarction; Norgestrel; Risk Factors

1989